(NASDAQ: ORKA) Oruka Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 13.72%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 19.77%.
Oruka Therapeutics's earnings in 2025 is -$34,399,000.On average, 7 Wall Street analysts forecast ORKA's earnings for 2025 to be -$102,146,768, with the lowest ORKA earnings forecast at -$301,337,516, and the highest ORKA earnings forecast at -$55,647,695. On average, 3 Wall Street analysts forecast ORKA's earnings for 2026 to be -$76,996,810, with the lowest ORKA earnings forecast at -$89,596,288, and the highest ORKA earnings forecast at -$68,597,158.
In 2027, ORKA is forecast to generate -$77,696,781 in earnings, with the lowest earnings forecast at -$85,746,448 and the highest earnings forecast at -$69,647,115.